Chemoreflex Gain on Exercise

Status

UNKNOWN

Phases

Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01050179

Enrollment

Registered

2010-01-15

Start date

2010-02-28

Completion date

2010-10-31

Last updated

2010-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exertional Periodic Breathing

Keywords

chemosensitivity

Brief summary

The purpose of this study is to assess chemoreflex gain on exercise.

Detailed description

Normally breathing is controlled by a reflex that responds to the levels of carbon dioxide (CO2) in the blood. The change in breathing that results from a change in the blood's CO2 concentration is called the chemoreflex. In heart failure, a condition where the heart muscle is damaged and can not pump as well, this reflex is exaggerated. The result of this can be breathing conditions characterised by patients hyperventilating at times and at other times taking very shallow breaths or even stopping altogether. In the past the only way of measuring this chemoreflex was to get patients to breathe into a large container and to rebreathe their exhaled air and allow the CO2 to rise over time, whilst keeping the oxygen constant. The proportion by which the ventilation increases with increasing carbon dioxide is the chemoreflex gain. Unfortunately, because this test takes a long time to conduct, requires specialist knowledge and equipment it has not been possible to measure this reflex on exercise.

Interventions

OTHERcarbon dioxide

sinusoidal carbon dioxide delivery

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

BASIC_SCIENCE

Masking

NONE

Eligibility

Sex/Gender

MALE

Age

18 Years to 80 Years

Healthy volunteers

Yes

Inclusion criteria

* Volunteers: Males aged 18-80 years who are able to perform both running and cycling and can follow simple visual instructions. * Heart Failure Subjects: Males aged 18-80 with a clinical diagnosis of heart failure who are able to perform both running and cycling and can follow simple visual instructions.

Exclusion criteria

* Chest pain of any cause within 4-6 days, * Pulmonary oedema, * Uncontrolled hypertension (systolic blood pressure \> 220 mm Hg, diastolic \>120 mm Hg), * Severe aortic stenosis, * Severe hypertrophic obstructive cardiomyopathy, * Untreated life threatening arrhythmia, * Dissecting aneurysm, * Recent surgery (within 4-6 weeks), COPD.

Design outcomes

Primary

Measure	Time frame
chemoreflex gain on exercise	every minute

Secondary

Measure	Time frame
Reproducibility of chemoreflex gain on exercise	every minute

Countries

United Kingdom

Contacts

Primary ContactDarrel P Francis, MD

darrel.francis@imperial.ac.uk+44 207 594 1093

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026